Archives of Dermatological Research

, Volume 295, Issue 12, pp 509–516

T cells in psoriatic lesional skin that survive conventional therapy with NB-UVB radiation display reduced IFN-γ expression

  • Gamze Piskin
  • Regien M. R. Sylva-Steenland
  • Jan D. Bos
  • Marcel B. M. Teunissen
Original Paper


The type 1 T cell-derived cytokine interferon γ (IFN-γ) is overexpressed in psoriatic lesional skin. Recently, we have shown that a single high erythemal dose of broad-band ultraviolet B (UVB) irradiation reduces type 1 and favors type 2, i.e. interleukin-4 (IL-4), cytokine expression in normal and psoriatic skin. In this study, we wanted to see whether conventional narrow-band UVB (NB-UVB) therapy (i.e. repeated exposure to nonerythemal doses) also affects type 1/type 2 cytokine expression of T cells present in chronic plaque type psoriatic lesions. Staining of cryostat sections showed decreased expression of both IFN-γ and IL-4 in situ after NB-UVB therapy. CD4+ dermal T cell lines, derived from psoriatic lesional skin, displayed significantly decreased intracellular IFN-γ expression during and after NB-UVB therapy as compared to pretreatment values. Intracellular IL-4 expression was increased in most patients after therapy. Analysis of the supernatants of these stimulated dermal T cells revealed that IFN-γ production decreased significantly following NB-UVB therapy, whereas IL-4 expression increased in the T cell supernatants from most patients, confirming the intracellular determinations. In addition, IL-10 and transforming growth factor-β levels in the supernatants appeared to be increased in the majority of patients following UVB therapy. Apart from the well-known killing effect of UVB on T cells, our results show that the improvement in psoriatic skin following NB-UVB therapy is also due to a reduced capacity of the surviving dermal T cells to express the proinflammatory cytokine IFN-γ.


Cytokine Th1 Th2 Immunosuppression IL-4 Phototherapy 


  1. 1.
    Uyemura K, Yamamura M, Fivenson DF, Modlin RL, Nickoloff BJ (1993) The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 101:701–705PubMedGoogle Scholar
  2. 2.
    Barna M, Snijdewint FG, van der Heijden FL, Bos JD, Kapsenberg ML (1994) Characterization of lesional psoriatic skin T lymphocyte clones. Acta Derm Venereol 186:9–11Google Scholar
  3. 3.
    Schlaak JF, Buslau M, Jochum W, et al (1994) T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 102:145–149PubMedGoogle Scholar
  4. 4.
    Vollmer S, Menssen A, Trommler P, Schendel D, Prinz JC (1994) T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24:2377–2382PubMedGoogle Scholar
  5. 5.
    Mozzanica N, Cattaneo A, Trabattoni D, et al (1995) Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients. Immunology 86:422–426PubMedGoogle Scholar
  6. 6.
    Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z, Cooper KD (1998) Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets. J Invest Dermatol 111:1072–1078PubMedGoogle Scholar
  7. 7.
    Austin LM, Ozawa M, Kikuchi T, Walters IB, Krueger JG (1999) The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 113:752–759PubMedGoogle Scholar
  8. 8.
    de Jong R, Bezemer AC, Zomerdijk TP, et al (1996) Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 26:2067–2074PubMedGoogle Scholar
  9. 9.
    Bozza M, Bliss JL, Dorner AJ, Trepicchio WL (2001) Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J Interferon Cytokine Res 21:21–30CrossRefPubMedGoogle Scholar
  10. 10.
    Asadullah K, Friedrich M, Hanneken S, et al (2001) Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings. J Invest Dermatol 116:721–727PubMedGoogle Scholar
  11. 11.
    Ghoreschi K, Thomas P, Breit S, et al (2003) Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 9:40–46CrossRefPubMedGoogle Scholar
  12. 12.
    Aberer W, Schuler G, Stingl G, Honigsmann H, Wolff K (1981) Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 76:202–210Google Scholar
  13. 13.
    Di Nuzzo S, de Rie MA, van der Loos CM, Bos JD, Teunissen MB (1996) Solar-simulated ultraviolet irradiation induces selective influx of CD4+ T lymphocytes in normal human skin. Photochem Photobiol 64:988–993PubMedGoogle Scholar
  14. 14.
    Hawk JL, Murphy GM, Holden CA (1988) The presence of neutrophils in human cutaneous ultraviolet-B inflammation. Br J Dermatol 118:27–30PubMedGoogle Scholar
  15. 15.
    Teunissen MB, Piskin G, Di Nuzzo S, Sylva-Steenland RM, de Rie MA, Bos JD (2002) Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses. J Immunol 168:3732–3739PubMedGoogle Scholar
  16. 16.
    Meunier L, Bata-Csorgo Z, Cooper KD (1995) In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1− macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. J Invest Dermatol 105:782–788PubMedGoogle Scholar
  17. 17.
    Gilliam AC, Kremer IB, Yoshida Y, et al (1998) The human hair follicle: a reservoir of CD40+ B7-deficient Langerhans cells that repopulate epidermis after UVB exposure. J Invest Dermatol 110:422–427Google Scholar
  18. 18.
    Shreedhar V, Giese T, Sung VW, Ullrich SE (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J Immunol 160:3783–3789PubMedGoogle Scholar
  19. 19.
    Di Nuzzo S, Sylva-Steenland RM, Koomen CW, et al (2002) UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell cultures. Photochem Photobiol 76:301–309PubMedGoogle Scholar
  20. 20.
    Kang K, Hammerberg C, Meunier L, Cooper KD (1994) CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 153:5256–5264PubMedGoogle Scholar
  21. 21.
    de Waal MR, Haanen J, Spits H, et al (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915–924PubMedGoogle Scholar
  22. 22.
    Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815–3822PubMedGoogle Scholar
  23. 23.
    D’Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041–1048PubMedGoogle Scholar
  24. 24.
    Lee HS, Kooshesh F, Sauder DN, Kondo S (1997) Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp Dermatol 6:105–110PubMedGoogle Scholar
  25. 25.
    Jeevan A, Ullrich SE, De Gracia M, Shah R, Sun Y (1996) Mechanism of UVB-induced suppression of the immune response to Mycobacterium bovis bacillus Calmette-Guerin: role of cytokines on macrophage function. Photochem Photobiol 64:259–266PubMedGoogle Scholar
  26. 26.
    Green C, Ferguson J, Lakshmipathi T, Johnson BE (1988) 311 nm UVB phototherapy—an effective treatment for psoriasis. Br J Dermatol 119:691–696Google Scholar
  27. 27.
    Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG (1997) Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 133:1514–1522CrossRefPubMedGoogle Scholar
  28. 28.
    El-Ghorr AA, Norval M (1997) Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B 38:99–106CrossRefPubMedGoogle Scholar
  29. 29.
    Bos JD, de Rie MA (1999) The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 20:40–46PubMedGoogle Scholar
  30. 30.
    Ozawa M, Ferenczi K, Kikuchi T, et al (1999) 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 189:711–718CrossRefPubMedGoogle Scholar
  31. 31.
    Jones CD, Guckian M, el Ghorr AA, Gibbs NK, Norval M (1996) Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 12:204–210PubMedGoogle Scholar
  32. 32.
    Piskin G, Koomen CW, Picavet D, Bos JD, Teunissen MB (2003) Ultraviolet-B irradiation decreases IFN-gamma and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. Exp Dermatol 12:172–180PubMedGoogle Scholar
  33. 33.
    Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedGoogle Scholar
  34. 34.
    Krueger JG, Wolfe JT, Nabeya RT, et al (1995) Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182:2057–2068PubMedGoogle Scholar
  35. 35.
    de Gruijl FR (1997) Health effects from solar UV radiation. Radiat Prot Dosimetry 72:177–196Google Scholar
  36. 36.
    Teunissen MB, Sylva-Steenland RM, Bos JD (1993) Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro. Clin Exp Immunol 94:208–213PubMedGoogle Scholar
  37. 37.
    Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 146:485–491PubMedGoogle Scholar
  38. 38.
    Toichi E, McCormick TS, Cooper KD (2002) Cell surface and cytokine phenotypes of skin immunocompetent cells involved in ultraviolet-induced immunosuppression. Methods 28:104–110CrossRefPubMedGoogle Scholar
  39. 39.
    Tjioe M, Smits T, van de Kerkhof PCM, Gerritsen MJP (2003) The differential effect of broad band versus narrow band UVB with respect to photodamage and cutaneous inflammation. Exp Dermatol 12:729–733PubMedGoogle Scholar
  40. 40.
    Piskin G, Tursen U, Bos JD, Teunissen MBM (2003) IL-4 expression by neutrophils in psoriasis lesional skin upon high dose UVB exposure. Dermatology 207:51–53CrossRefPubMedGoogle Scholar
  41. 41.
    Walters IB, Ozawa M, Cardinale I, et al (2003) Narrowband (312-nm) UV-B suppresses interferon gamma and interleukin (IL) 12 and increases IL-4 transcripts: differential regulation of cytokines at the single-cell level. Arch Dermatol 139:155–161PubMedGoogle Scholar
  42. 42.
    Asadullah K, Sterry W, Stephanek K, et al (1998) IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 101:783–794PubMedGoogle Scholar
  43. 43.
    Maloy KJ, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol 2:816–822PubMedGoogle Scholar
  44. 44.
    Kondo S, Hozumi Y, Maejima H, Aso K (1992) Organ culture of psoriatic skin: effect of TGF-alpha and TGF-beta on epidermal structure in vitro. Arch Dermatol Res 284:150–153PubMedGoogle Scholar
  45. 45.
    Malkani AK, Baker BS, Garioch JJ, et al (1993) Normal response to tumor necrosis factor-alpha and transforming growth factor-beta by keratinocytes in psoriasis. Exp Dermatol 2:224–230PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Gamze Piskin
    • 1
  • Regien M. R. Sylva-Steenland
    • 1
  • Jan D. Bos
    • 1
  • Marcel B. M. Teunissen
    • 1
  1. 1.Department of Dermatology, Academic Medical CenterUniversity of Amsterdam, Room L3-365DE AmsterdamThe Netherlands

Personalised recommendations